Idiopathic Normal Pressure Hydrocephalus (INPH)

5

Review clinical trials related to Idiopathic Normal Pressure Hydrocephalus (INPH). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Transcranial Ultrasound Assessment of Cerebral Pulsatility in Shunt Decision-making for Suspected Idiopathic Normal Pressure Hydrocephalus: a Prospective Cohort Study

This will be a single-center, prospective, analytical cohort study. All included patients will undergo transcranial ultrasound (TPI) with measurement of cerebral pulsatility parameters prior to subtractive lumbar puncture during hospitalization in the neurosurgery department, followed by a second ultrasound assessment either at one year after surgery for operated patients, or at one year after the initial ultrasound assessment for non-operated patients. This ultrasound evaluation will be integrated into the routine work-up, which is already systematically performed in cases of suspected idiopathic normal pressure hydrocephalus (iNPH). The neurosurgical team's decision to perform cerebrospinal fluid (CSF) shunting will be made blinded to the ultrasound measurements and based solely on the standard clinical protocol. The primary objective of the study is to demonstrate that the mean amplitude of cerebral pulsatility (MeanBTP) prior to subtractive lumbar puncture is significantly higher in patients who show clinical improvement 12 months after CSF shunting compared with those who do not, with a type I error risk (alpha) of 0.05."

Participants needed: 110
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, ToursUpdated: Apr 30, 2026Locations: 1
Eligibility criteria

Adult [+5]

Patients already fitted with a CSF shunting system (VPS) [+2]

Status: Recruiting

Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)

This study is a prospective, multicenter, observational cohort (patient registry) designed to better understand freezing of gait (FOG), a disabling walking problem that can occur in Parkinson's disease and other related neurological conditions.The purpose of this registry is to collect long-term clinical information from patients with freezing of gait or gait and balance problems, and to explore how different causes of FOG are related to symptoms, walking patterns, falls, disease progression, and outcomes over time. The study will include participants with Parkinson's disease and other conditions associated with freezing of gait.Participants will receive standard medical care as determined by their treating physicians. No experimental drugs or study-related treatments will be assigned as part of this registry. Clinical information will be collected during routine visits and follow-up assessments, including questionnaires, walking and balance evaluations, video recordings, and other commonly used clinical tests.The information collected in this study may help improve the understanding of freezing of gait, support better risk assessment for falls, and guide future research and clinical management strategies for patients with gait and balance disorders.

Participants needed: 700
Trial details
Age: 30-85Biological sex: AllType: ObservationalSponsor: Tianjin Huanhu HospitalUpdated: Mar 10, 2026Locations: 1Duration: 36 Months
Eligibility criteria

Age 30-85 years [+4]

Severe dementia (Mini-Mental State Examination score < 10) [+5]

Status: Not yet recruiting

Functional Outcomes After LumbOpenitoneal Shunt Placement UndeR Local Anesthesia for Patients With Idiopathic Normal preSsure Hydrocephalus (FLOURISH) Trial

This study is a prospective observational registry study that enrolls all patients aged 60 years or older suspected of having idiopathic normal pressure hydrocephalus based on the Third Edition of the Guidelines for the Diagnosis and Treatment of Idiopathic Normal Pressure Hydrocephalus. From the cohort registered, patients judged to be candidates for surgery based on the 3rd Edition of the Guidelines for the Diagnosis and Treatment of Idiopathic Normal Pressure Hydrocephalus. These patients will be randomized 1:1 to undergo either ventriculoperitoneal shunt surgery under general anesthesia or lumbar peritoneal shunt surgery under local anesthesia. A randomized clinical trial would attest the non-inferiority of lumbar peritoneal shunt surgery under local anesthesia compared to ventriculoperitoneal shunt surgery under general anesthesia regarding the improvement in timed up-and-go test scores at 3 months post-surgery relative to pre-surgery levels.

Participants needed: 196
Trial details
Phase: Phase 4Age: 60+Biological sex: AllType: InterventionalSponsor: Institute for Clinical Effectiveness, JapanUpdated: Mar 3, 2026Locations: 1
Eligibility criteria

Probable iNPH patients [+6]

Patients deemed unsuitable for lumbar-abdominal shunt surgery due to advanced de... [+2]

Status: Recruiting

Endoscopic Third Ventriculostomy vs. Ventriculoperitoneal Shunt in Idiopathic Normal Pressure Hydrocephalus (ENDOVEST)

The aim of this single-center, two-arm, open-labeled, randomized controlled clinical study is to compare two surgical interventions, endoscopic third ventriculostomy and ventriculoperitoneal shunt, in treating idiopathic normal pressure hydrocephalus in terms of clinical improvement.

Participants needed: 150
Trial details
Age: 40+Biological sex: AllType: InterventionalSponsor: University Hospital, Basel, SwitzerlandUpdated: Feb 3, 2025Locations: 1
Eligibility criteria

>40 years of age [+7]

≤40 years of age [+6]

Status: Recruiting

The Pilot Study of Medical Device-Neuclare for Patients With Idiopathic Normal Pressure Hydrocephalus (iNPH)

This clinical trial aims to explore the effectiveness and safety of gait improvemen of Neuclare, a science medical device, for patients with Idiopathic Normal Pressure Hydrocephalus (iNPH) Through methods such as Timed Up \& Go Test (TUG), 10m gait , iNPH grading scale), etc, gait improvement before and after using Neuclare will be evaluated.

Participants needed: 20
Trial details
Age: 60-90Biological sex: AllType: InterventionalSponsor: DeepsonbioUpdated: Dec 30, 2024Locations: 1
Eligibility criteria

Adults aged 60 to 90, regardless of gender [+4]

Patient with pathological lesions in the brain identified by MRI [+16]